← Home / BOSTON SCIENTIFIC CORP (BSX)
Stock Analysis
BOSTON SCIENTIFIC CORP (BSX)
BSX
BSX · Healthcare • Medical Devices
44.96 -2.26%
Track BSX in your personal workspace Monitor performance, SPY relative strength and WOI View from your watchlist.
Alert me when BSX price is:
52W Range Position
4%
LOWMIDHIGH
Trend
Vulnerable
Momentum
Neutral
Updated: 2026-07-31 14:44 UTC
WOI Investment Thesis
Vulnerable
Watch confirmation and invalidation levels before acting.
⚖️
✓
Fundamentals
Improving / Strong
✓
Price Structure
Vulnerable
•
Momentum
Neutral
×
Breakout Confirmation
Pending
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
—
↗
Break Above
Confirmation improves above resistance.
46.58
🎯
Next Objective
Pattern-derived target if setup continues.
—
×
Thesis Break
Scenario weakens below invalidation.
Below —
Recent Company Events
SEC VERIFIED
Latest material filings
JUL
29
●
Financial Results
HIGH
BSX reports financial results
On July 29, 2026, Boston Scientific Corporation issued a press release announcing financial results for the second quarter ended June 30, 2026.
8-K Filing • SEC EDGAR
MAY
18
↺
Share Repurchase
MEDIUM
BSX share repurchase update
Accelerated Share Repurchase Program On May 18, 2026, Boston Scientific Corporation (the “ Company ”) issued a press release announcing that the Company has entered into an accelerated share repurchase (“ ASR ”) agreement with JPMorgan Chase Bank, National Association for $2 billion (the “ Repurchase Price ”) of its...
8-K Filing • SEC EDGAR
MAY
5
●
Management / Board
MEDIUM
BSX board and management update
Amendments to Articles of Incorporation or Bylaws; Change in Fisal Year.
8-K Filing • SEC EDGAR
What's Driving BSX?
📈 Technical recovery is improving
Momentum is Neutral. Watch 46.58 for confirmation and — for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
—
Full Analysis Workspace
Technical Signal
Technical Setup Active
✓
An active technical structure is present. Use trigger, target, stop and watch levels for context.
Downtrend Structure
Downtrend line not broken yet · score 0
Trigger
88.54
Invalidation
88.54
RSI(14)
48.3
Price Chart
BSX — 1D Chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-07-30
Value
Value-oriented setup
Sales and book multiples are contained.
Market Cap
$64.4B
Company size
EV
$67.9B
Debt-adjusted value
P/E
18.1
Reasonable
P/S
3.1
Low sales multiple
P/B
2.5
Balanced
EV/Sales
3.3
Low sales multiple
EV/EBIT
17.9
Low multiple
P/FCF
18.5
Reasonable
FCF Yield
5.40%
Cash return
Source: SEC TTM data via WOI valuation cache Not financial advice
Business Lens
Strong financial quality
Growth, profitability, cash flow and balance sheet quality remain broadly supportive.
↗
Revenue Growth
Improving
●
Profitability
Strong
≈
Cash Flow
Positive
⚖
Balance Sheet
Strong
💵 Revenue
5.20B
↗ Improving
📈 Net Income
1.34B
↗ Strong
🧮 EPS (Basic)
0.90
↗ Strong
BOSTON SCIENTIFIC CORP
Healthcare • Medical Devices
Related Opportunities